Novel Etodolac-Based 1,2,4-Triazole Derivatives as Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Study

A series of novel 1,2,4-triazole nonsteroidal anti-inflammatory drugs (NSAIDs) derived from etodolac were designed and synthesized. The synthesized compounds were identified using 1 H and 13 C NMR, IR, and mass spectra and elemental analyses and evaluated for their in vitro antibacterial activity ag...

Full description

Saved in:
Bibliographic Details
Published inRussian journal of organic chemistry Vol. 56; no. 12; pp. 2179 - 2187
Main Authors Shaik, A., Rao, A. T., Venkatarao, D. V., Rao, S. V. M. Mohan, Kishore, P. V. V. N.
Format Journal Article
LanguageEnglish
Published Moscow Pleiades Publishing 01.12.2020
Springer Nature
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of novel 1,2,4-triazole nonsteroidal anti-inflammatory drugs (NSAIDs) derived from etodolac were designed and synthesized. The synthesized compounds were identified using 1 H and 13 C NMR, IR, and mass spectra and elemental analyses and evaluated for their in vitro antibacterial activity against Gram-positive microorganisms like Streptococcus pneumoniae and Klebsiella pneumoniae and Gram-negative strains such as Pseudomonas aeruginosa and Enterobacter cloacae with pefloxacin as a reference drug. Some compounds showed a potent activity at a concentration 50 mg/mL with inhibition zones of 30 to 36 mm against S. pneumoniae . Etodolac-derived N -isobutyl- and N -ethyl-1,2,4-triazoles containing 4-methoxybenzylsulfanyl and 3-nitrobenzylsulfanyl groups were active against P. aeruginosa with inhibition zones of 25–29 mm at a concentration of 50 mg/mL. All compounds showed excellent antioxidant activity with IC 50 values ranging from 72.39±0.25 µg/mL to 16.39±0.65 µg/mL in comparison with ascorbic acid (IC 50 16.81±0.18 µg/mL). Molecular docking studies revealed strong hydrogen bonding, π–π, and π–σ interactions of 3-nitro-, 4-methoxy-, and 4-methylbenzyl moieties with Ser421, Val120, Tyr124, Phe319, Ala44, and Val120 amino acid residues of the active site of glycogen synthase kinase-3 (GSK-3) protein.
ISSN:1070-4280
1608-3393
DOI:10.1134/S1070428020120210